Antibody-drug conjugate targeting ALK could treat neuroblastoma

DISEASE CATEGORY: Cancer

INDICATION: Neuroendocrine tumors

Cell and mouse studies identified an ALK-targeting antibody-drug conjugate (ADC) that could help treat

Read the full 198 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE